341 related articles for article (PubMed ID: 26878899)
1. Analysis of Iterative Screening with Stepwise Compound Selection Based on Novartis In-house HTS Data.
Paricharak S; IJzerman AP; Bender A; Nigsch F
ACS Chem Biol; 2016 May; 11(5):1255-64. PubMed ID: 26878899
[TBL] [Abstract][Full Text] [Related]
2. Using information from historical high-throughput screens to predict active compounds.
Riniker S; Wang Y; Jenkins JL; Landrum GA
J Chem Inf Model; 2014 Jul; 54(7):1880-91. PubMed ID: 24933016
[TBL] [Abstract][Full Text] [Related]
3. Evolution of Novartis' Small Molecule Screening Deck Design.
Schuffenhauer A; Schneider N; Hintermann S; Auld D; Blank J; Cotesta S; Engeloch C; Fechner N; Gaul C; Giovannoni J; Jansen J; Joslin J; Krastel P; Lounkine E; Manchester J; Monovich LG; Pelliccioli AP; Schwarze M; Shultz MD; Stiefl N; Baeschlin DK
J Med Chem; 2020 Dec; 63(23):14425-14447. PubMed ID: 33140646
[TBL] [Abstract][Full Text] [Related]
4. Rethinking molecular similarity: comparing compounds on the basis of biological activity.
Petrone PM; Simms B; Nigsch F; Lounkine E; Kutchukian P; Cornett A; Deng Z; Davies JW; Jenkins JL; Glick M
ACS Chem Biol; 2012 Aug; 7(8):1399-409. PubMed ID: 22594495
[TBL] [Abstract][Full Text] [Related]
5. Data-Driven Derivation of an "Informer Compound Set" for Improved Selection of Active Compounds in High-Throughput Screening.
Paricharak S; IJzerman AP; Jenkins JL; Bender A; Nigsch F
J Chem Inf Model; 2016 Sep; 56(9):1622-30. PubMed ID: 27487177
[TBL] [Abstract][Full Text] [Related]
6. Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity.
Sukuru SC; Jenkins JL; Beckwith RE; Scheiber J; Bender A; Mikhailov D; Davies JW; Glick M
J Biomol Screen; 2009 Jul; 14(6):690-9. PubMed ID: 19531667
[TBL] [Abstract][Full Text] [Related]
7. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel scaffolds for Rho kinase 2 inhibitor through TRFRET-based high throughput screening assay.
Oh KS; Mun J; Cho JE; Lee S; Yi KY; Lim CJ; Lee JS; Park WJ; Lee BH
Comb Chem High Throughput Screen; 2013 Jan; 16(1):37-46. PubMed ID: 22934984
[TBL] [Abstract][Full Text] [Related]
9. Biodiversity of small molecules--a new perspective in screening set selection.
Petrone PM; Wassermann AM; Lounkine E; Kutchukian P; Simms B; Jenkins J; Selzer P; Glick M
Drug Discov Today; 2013 Jul; 18(13-14):674-80. PubMed ID: 23454345
[TBL] [Abstract][Full Text] [Related]
10. Optimal HTS Fingerprint Definitions by Using a Desirability Function and a Genetic Algorithm.
Cortes Cabrera A; Petrone PM
J Chem Inf Model; 2018 Mar; 58(3):641-646. PubMed ID: 29425455
[TBL] [Abstract][Full Text] [Related]
11. Ligand efficiency based approach for efficient virtual screening of compound libraries.
Ke YY; Coumar MS; Shiao HY; Wang WC; Chen CW; Song JS; Chen CH; Lin WH; Wu SH; Hsu JT; Chang CM; Hsieh HP
Eur J Med Chem; 2014 Aug; 83():226-35. PubMed ID: 24960626
[TBL] [Abstract][Full Text] [Related]
12. Statistical molecular design: a tool to follow up hits from small-molecule screening.
Lindgren AE; Larsson A; Linusson A; Elofsson M
Methods Mol Biol; 2014; 1056():169-88. PubMed ID: 24306873
[TBL] [Abstract][Full Text] [Related]
13. Changing the HTS Paradigm: AI-Driven Iterative Screening for Hit Finding.
Dreiman GHS; Bictash M; Fish PV; Griffin L; Svensson F
SLAS Discov; 2021 Feb; 26(2):257-262. PubMed ID: 32808550
[TBL] [Abstract][Full Text] [Related]
14. Efficient search of chemical space: navigating from fragments to structurally diverse chemotypes.
Wassermann AM; Kutchukian PS; Lounkine E; Luethi T; Hamon J; Bocker MT; Malik HA; Cowan-Jacob SW; Glick M
J Med Chem; 2013 Nov; 56(21):8879-91. PubMed ID: 24117015
[TBL] [Abstract][Full Text] [Related]
15. Plate-based diversity subset screening generation 2: an improved paradigm for high-throughput screening of large compound files.
Bell AS; Bradley J; Everett JR; Loesel J; McLoughlin D; Mills J; Peakman MC; Sharp RE; Williams C; Zhu H
Mol Divers; 2016 Nov; 20(4):789-803. PubMed ID: 27631533
[TBL] [Abstract][Full Text] [Related]
16. A high-throughput screen reveals new small-molecule activators and inhibitors of pantothenate kinases.
Sharma LK; Leonardi R; Lin W; Boyd VA; Goktug A; Shelat AA; Chen T; Jackowski S; Rock CO
J Med Chem; 2015 Feb; 58(3):1563-8. PubMed ID: 25569308
[TBL] [Abstract][Full Text] [Related]
17. Accurate Hit Estimation for Iterative Screening Using Venn-ABERS Predictors.
Buendia R; Kogej T; Engkvist O; Carlsson L; Linusson H; Johansson U; Toccaceli P; Ahlberg E
J Chem Inf Model; 2019 Mar; 59(3):1230-1237. PubMed ID: 30726080
[TBL] [Abstract][Full Text] [Related]
18. Identification of Novel Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors by Kinase Activity-Based High-Throughput Screening for Anticancer Therapeutics.
Zhang W; Hu X; Chakravarty H; Yang Z; Tam KY
ACS Comb Sci; 2018 Nov; 20(11):660-671. PubMed ID: 30350563
[TBL] [Abstract][Full Text] [Related]
19. BonMOLière: Small-Sized Libraries of Readily Purchasable Compounds, Optimized to Produce Genuine Hits in Biological Screens across the Protein Space.
Mathai N; Stork C; Kirchmair J
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360558
[TBL] [Abstract][Full Text] [Related]
20. A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules.
Fouda A; Tahsini M; Khodayarian F; Al-Nafisah F; Rafei M
J Vis Exp; 2017 Mar; (121):. PubMed ID: 28362377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
